Bleakley Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54M Buy
45,004
+6,552
+17% +$6.69M 0.69% 35
2026
Q1
$35.4M Buy
38,452
+2,482
+7% +$2.52M 0.55% 41
2025
Q4
$38.7M Buy
35,970
+4,759
+15% +$4.55M 0.67% 37
2025
Q3
$23.8M Sell
31,211
-1,528
-5% -$1.14M 0.55% 39
2025
Q2
$25.5M Buy
32,739
+5,130
+19% +$3.99M 0.65% 36
2025
Q1
$22.8M Buy
27,609
+1,568
+6% +$1.3M 0.73% 28
2024
Q4
$20.1M Buy
26,041
+708
+3% +$586K 0.61% 31
2024
Q3
$22.4M Sell
25,333
-22,596
-47% -$20.3M 0.68% 26
2024
Q2
$43.4M Sell
47,929
-276
-0.6% -$221K 1.25% 15
2024
Q1
$37.5M Buy
48,205
+2,041
+4% +$1.45M 1.09% 16
2023
Q4
$26.9M Buy
46,164
+119
+0.3% +$69.5K 0.86% 18
2023
Q3
$24.7M Sell
46,045
-7,025
-13% -$3.62M 0.87% 18
2023
Q2
$24.9M Buy
53,070
+1,165
+2% +$489K 0.78% 20
2023
Q1
$17.8M Buy
51,905
+6,474
+14% +$2.18M 0.6% 29
2022
Q4
$16.6M Buy
+45,431
New +$16.1M 0.59% 30

Other funds holding LLY

Bleakley Financial Group's LLY Position: Q2 2026 in Review

Bleakley Financial Group increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $6.69M and bringing the position to 45,004 shares worth $54M. The position accounts for 0.69% of the portfolio, ranked #35.

Bleakley Financial Group first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bleakley Financial Group held 45,004 shares of Eli Lilly worth $54M as of Q2 2026.
  • Bleakley Financial Group bought 6,552 Eli Lilly shares in Q2 2026, an estimated $6.69M.
  • Eli Lilly made up 0.69% of Bleakley Financial Group's portfolio in Q2 2026, its #35 holding.
  • Bleakley Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.